Origami Surgical Inc.

Origami Surgical Inc. develops StitchKit, a specialized device designed to address a critical patient safety and operational efficiency challenge in robotic minimally invasive surgery: the management of exposed needle transfer during surgical procedures. The company's core focus is on preventing retained surgical sharps—a never event associated with significant morbidity, extended operative time, and substantial additional medical costs ($70,000–$200,000 per incident). StitchKit optimizes both safety and surgical efficiency by reducing needle exchanges during procedures, eliminating the risk of lost needles, and enhancing surgeon autonomy. Clinical evidence from published studies in 422 patients demonstrates safety and efficacy, with no reported hernias, infections, or adverse events. The device also enables reduction of operative ports and decreases reliance on skilled bedside assistants. Origami Surgical targets robotic surgery programs and OR teams performing minimally invasive procedures where needle management is a recurring operational and safety concern. The company positions itself in the growing robotic surgery market (15.7% CAGR over 10 years) where 91% of surgeons report one to five lost sharps incidents annually, with over 80% of needle loss occurring during trocar retrieval.